A 52-year-old woman with a 10-year history of myasthenia gravis (MG) is on long-term neostigmine therapy. She presents to the neurology clinic for routine follow-up. Her neurologist explains that she has developed a tolerance to the drug and is considering switching to a longer-acting agent. The neurologist also mentions the risk of a "cholinergic crisis" if the dose is increased too much. Which of the following best explains the mechanism of cholinergic crisis in myasthenia gravis patients on excessive cholinesterase inhibitors?

Explanation

## Cholinergic Crisis in Myasthenia Gravis ### Normal Neuromuscular Transmission in MG In myasthenia gravis, autoimmune destruction of nicotinic acetylcholine receptors (AChR) at the neuromuscular junction reduces the safety margin for neuromuscular transmission. Cholinesterase inhibitors (e.g., neostigmine, pyridostigmine) prolong acetylcholine (ACh) dwell time to compensate. ### The Paradox: Cholinergic Crisis **Key Point:** Excessive acetylcholine causes a **depolarization blockade** (also called desensitization blockade), which paradoxically worsens muscle weakness despite increased ACh availability. ### Mechanism of Depolarization Blockade ```mermaid flowchart TD A[Normal dose of cholinesterase inhibitor]:::action --> B[Moderate ↑ ACh at NMJ]:::outcome B --> C[Nicotinic receptors activated]:::action C --> D[Depolarization + muscle contraction]:::outcome E[Excessive dose of cholinesterase inhibitor]:::urgent --> F[Massive ↑ ACh at NMJ]:::urgent F --> G[Sustained depolarization]:::urgent G --> H[Nicotinic receptors desensitized]:::urgent H --> I[Failure of neuromuscular transmission]:::urgent I --> J[Paradoxical muscle weakness]:::urgent ``` ### Two Phases of Depolarization Blockade | Phase | Mechanism | Clinical Effect | |-------|-----------|----------------| | **Phase I (Initial)** | Sustained depolarization from excessive ACh | Brief muscle fasciculations, then weakness | | **Phase II (Desensitization)** | Nicotinic receptors become refractory to ACh despite continued depolarization | Persistent muscle paralysis (cannot be reversed by more ACh) | **High-Yield:** In cholinergic crisis, the neuromuscular junction is **flooded with ACh**, but the receptors cannot respond because they are in a desensitized state. More cholinesterase inhibitor makes it worse, not better. ### Clinical Features of Cholinergic Crisis **Nicotinic effects** (at NMJ): - Muscle weakness and fasciculations - Respiratory paralysis (life-threatening) **Muscarinic effects** (autonomic overstimulation): - Excessive salivation, lacrimation, bronchospasm - Bradycardia, hypotension - Miosis, muscle fasciculations ### Distinguishing Myasthenic vs. Cholinergic Crisis | Feature | Myasthenic Crisis | Cholinergic Crisis | |---------|-------------------|-------------------| | **Cause** | Inadequate ACh (under-treatment) | Excessive ACh (over-treatment) | | **Pupil size** | Normal or dilated | Pinpoint (miosis) | | **Salivation** | Dry mouth | Excessive salivation | | **Fasciculations** | Absent | Present | | **Response to edrophonium** | Improves (diagnostic) | Worsens (contraindicated) | | **Treatment** | Increase cholinesterase inhibitor | Discontinue; give atropine | **Clinical Pearl:** The **Tensilon (edrophonium) test** can differentiate the two crises: improvement = myasthenic crisis; worsening = cholinergic crisis. However, this test is now rarely used due to safety concerns; clinical judgment and response to treatment are preferred. **Mnemonic for cholinergic crisis symptoms: SLUDGE + Muscle weakness** - **S**alivation ↑ - **L**acrimation ↑ - **U**rination ↑ - **D**efecation ↑ - **G**astric secretion ↑ - **E**mesis ↑ - **Muscle weakness** (from depolarization blockade)